Lombard Odier Asset Management Europe Ltd Sells 70,008 Shares of Bruker Corporation $BRKR

Lombard Odier Asset Management Europe Ltd lessened its position in shares of Bruker Corporation (NASDAQ:BRKR) by 51.4% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 66,216 shares of the medical research company’s stock after selling 70,008 shares during the period. Lombard Odier Asset Management Europe Ltd’s holdings in Bruker were worth $2,392,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Orbis Allan Gray Ltd acquired a new stake in Bruker during the 2nd quarter worth about $192,735,000. Price T Rowe Associates Inc. MD lifted its stake in shares of Bruker by 2,963.4% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 2,366,520 shares of the medical research company’s stock valued at $111,488,000 after purchasing an additional 2,289,269 shares during the period. AQR Capital Management LLC lifted its stake in shares of Bruker by 125.3% in the 2nd quarter. AQR Capital Management LLC now owns 3,326,820 shares of the medical research company’s stock valued at $137,065,000 after purchasing an additional 1,850,215 shares during the period. Franklin Resources Inc. boosted its position in shares of Bruker by 317.7% during the 4th quarter. Franklin Resources Inc. now owns 2,309,404 shares of the medical research company’s stock valued at $108,796,000 after purchasing an additional 1,756,460 shares in the last quarter. Finally, Millennium Management LLC boosted its position in shares of Bruker by 222.6% during the 4th quarter. Millennium Management LLC now owns 1,839,587 shares of the medical research company’s stock valued at $86,663,000 after purchasing an additional 1,269,316 shares in the last quarter. Institutional investors and hedge funds own 79.52% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have weighed in on BRKR. TD Cowen reiterated a “hold” rating on shares of Bruker in a report on Wednesday, July 15th. JPMorgan Chase & Co. increased their price target on Bruker from $55.00 to $65.00 and gave the stock an “overweight” rating in a report on Monday, June 8th. Citigroup raised their price objective on shares of Bruker from $44.00 to $60.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 8th. Wolfe Research started coverage on shares of Bruker in a research note on Monday, June 1st. They issued a “peer perform” rating for the company. Finally, Stifel Nicolaus set a $45.00 target price on shares of Bruker in a research report on Friday, May 8th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $56.79.

Bruker Stock Performance

NASDAQ BRKR opened at $62.84 on Monday. The company has a market cap of $9.57 billion, a P/E ratio of -261.83, a PEG ratio of 2.01 and a beta of 1.28. The company has a fifty day simple moving average of $58.15 and a 200 day simple moving average of $46.61. The company has a current ratio of 1.55, a quick ratio of 0.72 and a debt-to-equity ratio of 0.67. Bruker Corporation has a 12-month low of $28.53 and a 12-month high of $65.30.

Bruker (NASDAQ:BRKR) last released its quarterly earnings data on Wednesday, May 6th. The medical research company reported $0.31 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.08. Bruker had a negative net margin of 0.65% and a positive return on equity of 11.60%. The firm had revenue of $823.40 million for the quarter, compared to the consensus estimate of $795.62 million. During the same quarter in the prior year, the company posted $0.47 earnings per share. The business’s revenue was up 2.7% on a year-over-year basis. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. Sell-side analysts predict that Bruker Corporation will post 2.12 earnings per share for the current fiscal year.

Bruker Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, July 7th. Investors of record on Monday, June 22nd were issued a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date was Monday, June 22nd. Bruker’s dividend payout ratio is currently -83.33%.

About Bruker

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.